Current filters:  
India
Healthcare
Life Sciences, Biotechnology & Nanotechnology
India
Ikigai Law
The framework was reportedly circulated with companies and government departments in May 2023, but has not been released for public consultation.
Ikigai Law
Medical devices companies get more time to comply with medical devices law.
Nexdigm Private Limited
The COVID-19 pandemic put a spotlight on healthcare systems across the globe and exposed areas of improvement within the system.
Majmudar & Partners
The Drugs, Medical Devices and Cosmetics Bill, 2023 (the "Drugs Bill") seeks to replace the Drugs and Cosmetics Act, 1940 (the "Drugs Act")...
Nexdigm Private Limited
Indian State Governments offer varied incentives under their respective state industrial development corporation policies to promote the set-up of new manufacturing units in the state.
S&A Law Offices
Intellectual Property Rights (IPR) play a crucial role in fostering innovation and protecting the interests of creators and inventors.
LexOrbis
There are more than 220 viruses that are known to infect humans. Within this field of viruses, RNA viruses dominate the current list of ten global health threats.
IndusLaw
The recent developments in the healthcare and pharma industry primarily focuses on high quality pharmacy education and equitable access to healthcare coupled with classification of certain new medical devices.
Intepat IP
The Department of Biotechnology (DBT), under the Ministry of Science & Technology, recently notified that the DBT Intellectual Property Guidelines in September 2023.
De Penning & De Penning
Artificial intelligence (AI) is driving a transformative wave in the pharmaceutical and biotechnology sectors. Its integration into drug discovery, diagnostics, and clinical trials...
LexOrbis
Using a combination of known elements to create a new invention is an age-old practice to stay ahead in competition.
IndusLaw
Martin Luther King Junior famously said, "Of all the forms of inequality, injustice in health is the most shocking and inhumane." Echoing this assertion, in the recently concluded...
Saikrishna & Associates
The recent past has seen a few blogposts on how public interest is factored in (or isn't) by courts. A post looking at public interest as viewed in interim injunctions for pharma cases
Luthra and Luthra Law Offices India
Pharmaceutical disputes, being the largest and fastest-growing business sectors in the world are increasingly being settled through international arbitration, particularly in the context of ...
Nexdigm Private Limited
The Government of India (GoI) has focused on encouraging manufacturing in India and introducing innovative technologies.
LexOrbis
In the recent case of Dr. Reddy's Laboratories Ltd vs Fast Cure Pharma, the plaintiff applied to the Delhi High Court for a permanent injunction restraining the defendant from manufacturing...
Accures Legal
In that is trying to open different doors of inventions in the scientific community from RNA-Cancer vaccines to genetically modified organisms.
Dentons Link Legal
Medical and Healthcare Technology ("MedTech") is a sunrise sector in the Indian economy, with startups and MNCs growing at rapid pace with an estimated growth from US$ 11 billion to US$ 50 billion by 2030 at 16.4% CAGR.
Shardul Amarchand Mangaldas & Co
The Parliament on 1 August 2023 passed the Biological Diversity (Amendment) Bill, 2023 which amends the Biological Diversity Act, 2002.
IndusLaw
In August 2023, the Government of India (GoI) notified the Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP Scheme)1 with a total budgetary outlay...
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media